Category: Clinical Trial
Clinical Trial market research reports by GlobalData
-
Mpox (Monkeypox) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Mpox (Monkeypox) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in mpox therapeutics. In the 10 pharmaceutical markets covered in GlobalData’s epidemiology fact she ... Read More
-
Vertigo Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Vertigo Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Vertigo Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and To ... Read More
-
Renal Cell Carcinoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Renal Cell Carcinoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Renal Cell Carcinoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, S ... Read More
-
Narcolepsy Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Narcolepsy Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Narcolepsy therapeutics. There will be more than 900,000 diagnosed prevalent cases of narcolepsy in 202 ... Read More
-
Alpha-1 Antitrypsin Deficiency (A1AD) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Alpha-1 Antitrypsin Deficiency (A1AD) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Alpha-1 Antitrypsin Deficiency (A1AD) Clinical Trial Analysis by Trial Phase, Trial S ... Read More
-
Alzheimer’s Disease Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2030
Alzheimer’s Disease Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2030 Summary This report covers the 8mm (US, France, Germany, Italy, Spain, UK, Japan, China) and provides an ... Read More
-
Dementia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Dementia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Dementia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and ... Read More
-
Chronic Low Back Pain (CLBP) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Chronic Low Back Pain (CLBP) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in CLBP therapeutics. There will be more than 344 million prevalent cases of CLBP in 202 ... Read More
-
Rhabdomyosarcoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Rhabdomyosarcoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Rhabdomyosarcoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, S ... Read More
-
Muscle Invasive Bladder Cancer (MIBC) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Muscle Invasive Bladder Cancer (MIBC) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Muscle Invasive Bladder Cancer Clinical Trial Analysis by Trial Phase, Trial Status, ... Read More
-
Hyperglycemia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Hyperglycemia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Hyperglycemia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor ... Read More
-
Post-Traumatic Stress Disorder (PTSD) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Post-Traumatic Stress Disorder (PTSD) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Post-Traumatic Stress Disorder (PTSD) Clinical Trial Analysis by Trial Phase, Trial S ... Read More
-
Diabetic Macular Edema Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Diabetic Macular Edema Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Diabetic Macular Edema Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Point ... Read More
-
Multiple Myeloma (Kahler Disease) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Multiple Myeloma (Kahler Disease) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Multiple Myeloma (Kahler Disease) Clinical Trial Analysis by Trial Phase, Trial Status, T ... Read More
-
Clinical Trials - Impact of COVID-19 and Long COVID
Clinical Trials - Impact of COVID-19 and Long COVID Summary This report provides an overview of global COVID-19 clinical trials, long COVID clinical trials, and trials disrupted by COVID-19. Scope The clinical trials data used for these analyses were extracted from GlobalData’s Clinical Trials Datab ... Read More
-
Psoriatic Arthritis (PsA) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Psoriatic Arthritis (PsA) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in PsA therapeutics. There will be more than 6 million prevalent cases of PsA in 2023 in th ... Read More
-
Lewy Body Dementia (LBD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Lewy Body Dementia (LBD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in LBD therapeutics. There will be more than 1.1 million diagnosed prevalent cases of LBD in ... Read More
-
Short Bowel Syndrome (SBS) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Short Bowel Syndrome (SBS) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in SBS There will be more than 94,000 diagnosed prevalent cases of SBS in 2023 in the 16 c ... Read More
-
Myocardial Infarction (MI) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Myocardial Infarction (MI) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in MI therapeutics. There will be 74,405,699 diagnosed prevalent cases of MI in 2023 in th ... Read More
-
Body Dysmorphic Disorder (BDD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Body Dysmorphic Disorder (BDD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in BDD therapeutics. There will be 67,698,071 total prevalent cases of BDD in 2023 in ... Read More
-
Duchenne Muscular Dystrophy Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Duchenne Muscular Dystrophy Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Duchenne Muscular Dystrophy - Global Clinical Trials Review, 2023 provides an overview of Duche ... Read More
-
Amyotrophic Lateral Sclerosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Amyotrophic Lateral Sclerosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Amyotrophic Lateral Sclerosis - Global Clinical Trials Review, 2023 provides an overview of A ... Read More
-
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Global Clinical Tria ... Read More
-
Inflammatory Bowel Disease Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Inflammatory Bowel Disease Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Inflammatory Bowel Disease - Global Clinical Trials Review, 2023 provides an overview of Inflamm ... Read More
-
Ankylosing Spondylitis (Bekhterev's Disease) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Ankylosing Spondylitis (Bekhterev's Disease) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Ankylosing Spondylitis (Bekhterev's Disease) - Global Clinical Trials Review, ... Read More
Research Assistance
